GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raia Drogasil SA (BSP:RADL3) » Definitions » Equity-to-Asset

Raia Drogasil (BSP:RADL3) Equity-to-Asset : 0.30 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Raia Drogasil Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Raia Drogasil's Total Stockholders Equity for the quarter that ended in Dec. 2023 was R$5,956 Mil. Raia Drogasil's Total Assets for the quarter that ended in Dec. 2023 was R$20,094 Mil. Therefore, Raia Drogasil's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.30.

The historical rank and industry rank for Raia Drogasil's Equity-to-Asset or its related term are showing as below:

BSP:RADL3' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3   Med: 0.4   Max: 0.61
Current: 0.3

During the past 13 years, the highest Equity to Asset Ratio of Raia Drogasil was 0.61. The lowest was 0.30. And the median was 0.40.

BSP:RADL3's Equity-to-Asset is ranked worse than
69.33% of 675 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs BSP:RADL3: 0.30

Raia Drogasil Equity-to-Asset Historical Data

The historical data trend for Raia Drogasil's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raia Drogasil Equity-to-Asset Chart

Raia Drogasil Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.32 0.32 0.31 0.30

Raia Drogasil Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.30 0.31 0.30 0.30

Competitive Comparison of Raia Drogasil's Equity-to-Asset

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Equity-to-Asset falls into.



Raia Drogasil Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Raia Drogasil's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=5956.001/20094.412
=0.30

Raia Drogasil's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=5956.001/20094.412
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Raia Drogasil  (BSP:RADL3) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Raia Drogasil Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Raia Drogasil's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Raia Drogasil (BSP:RADL3) Business Description

Traded in Other Exchanges
Address
Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-9000
Raia Drogasil SA is a large retail drug store operator in Brazil. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumery, cosmetics, household items, and personal care products. The company also acts as a pharmacy benefit manager, performing medical purchases with prenegotiated discounts. The majority of Raia Drogasil's revenue is generated through branded drug sales, while the bulk of the remaining revenue stems from perfumery, over-the-counter drugs, and generic drugs. The company owns a variety of stakes in operational subsidiaries.

Raia Drogasil (BSP:RADL3) Headlines

No Headlines